Carie Boyd Pharmaceuticals Email Format
Pharmaceutical ManufacturingTexas, United States51-200 Employees
Carie Boyd Pharmaceuticals specializes in compounding medications for office use and individual patient needs. It operates as an FDA-registered 503B outsourced compounding facility and a 503A specialty prescription compounding pharmacy, serving healthcare providers and patients nationwide. From its state-of-the-art facility, the operation adheres to FDA regulations and standards to produce a broad range of customized medications for its partner networks. The company began as a community pharmacy in 1965 in the Dallas–Fort Worth area, building expertise in hormone therapies and implantable hormone pellets. In 2015 it registered with the FDA as a 503B outsourced facility serving healthcare professionals, and in 2019 it relocated to Irving, Texas, to support expanded capacity.